APA (7th ed.) Citation

Y, F., R, M., T, H., N, H., T, N., Y, T., . . . N, Y. (2023). Pharmacokinetic and dose-finding study of osimertinib in patients with impaired renal function and low body weight. Cancer science, 114(5), 2087. https://doi.org/10.1111/cas.15736

Chicago Style (17th ed.) Citation

Y, Fujiwara, et al. "Pharmacokinetic and Dose-finding Study of Osimertinib in Patients with Impaired Renal Function and Low Body Weight." Cancer Science 114, no. 5 (2023): 2087. https://doi.org/10.1111/cas.15736.

MLA (9th ed.) Citation

Y, Fujiwara, et al. "Pharmacokinetic and Dose-finding Study of Osimertinib in Patients with Impaired Renal Function and Low Body Weight." Cancer Science, vol. 114, no. 5, 2023, p. 2087, https://doi.org/10.1111/cas.15736.